Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

Nanruoyi Zhou; Maria Velez; Benjamin Bachrach; Jaklin Gukasyan; Charlene Fares; Amy Cummings; Jackson Lind-Lebuffe; Wisdom Akingbemi; Debory Li; Paige Brodrick; Nawal Yessuf; Sarah Rettinger; Tristan Grogan; Philippe Rochigneux; Jonathan Goldman; Edward Garon; Aaron Lisberg

doi:10.1016/j.lungcan.2021.08.009

Journal Articles Lung Cancer Year : 2021

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (1) , (3, 4, 1) , (1) , (1) , (1)

1
2
3
4

Nanruoyi Zhou

Function : Author

University of California [Los Angeles]

Maria Velez

Function : Author

University of California [Los Angeles]

Benjamin Bachrach

Function : Author

University of California [Los Angeles]

Jaklin Gukasyan

Function : Author

University of California [Los Angeles]

Charlene Fares

Function : Author

University of California [Los Angeles]

Amy Cummings

Function : Author

University of California [Los Angeles]

Jackson Lind-Lebuffe

Function : Author

University of California [Los Angeles]

Wisdom Akingbemi

Function : Author

University of California [Los Angeles]

Debory Li

Function : Author

University of California [Los Angeles]

Paige Brodrick

Function : Author

University of California [Los Angeles]

Nawal Yessuf

Function : Author

University of California [Los Angeles]

Sarah Rettinger

Function : Author

Providence Hlth & Serv

Tristan Grogan

Function : Author

University of California [Los Angeles]

Philippe Rochigneux

Function : Author
PersonId : 754863
IdHAL : philippe-rochigneux
ORCID : 0000-0001-7932-0530
IdRef : 159209404

Institut Paoli-Calmettes

Centre de Recherche en Cancérologie de Marseille

University of California [Los Angeles]

CV

Jonathan Goldman

Function : Author

University of California [Los Angeles]

Edward Garon

Function : Author

University of California [Los Angeles]

Aaron Lisberg

Function : Author

University of California [Los Angeles]

Domains

Life Sciences [q-bio]

Philippe ROCHIGNEUX : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03689919

Submitted on : Tuesday, June 7, 2022-4:41:45 PM

Last modification on : Tuesday, November 29, 2022-12:06:07 PM

Dates and versions

hal-03689919 , version 1 (07-06-2022)

Identifiers

HAL Id : hal-03689919 , version 1
DOI : 10.1016/j.lungcan.2021.08.009
PUBMEDCENTRAL : PMC8923054

Cite

Nanruoyi Zhou, Maria Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene Fares, et al.. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC. Lung Cancer, 2021, 161, pp.34-41. ⟨10.1016/j.lungcan.2021.08.009⟩. ⟨hal-03689919⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CNRS UNIV-AMU CRCM

4 View

0 Download

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share